Serological differentiation between COVID-19 and SARS infections.
Antibodies, Viral
/ blood
Betacoronavirus
/ immunology
COVID-19
COVID-19 Testing
Clinical Laboratory Techniques
/ methods
Coronavirus Infections
/ diagnosis
Coronavirus Nucleocapsid Proteins
Cross Reactions
Diagnosis, Differential
Enzyme-Linked Immunosorbent Assay
/ methods
HEK293 Cells
Humans
Immunoprecipitation
Nucleocapsid Proteins
/ immunology
Pandemics
Phosphoproteins
Pneumonia, Viral
/ diagnosis
Protein Domains
/ immunology
Severe acute respiratory syndrome-related coronavirus
/ immunology
SARS-CoV-2
Serologic Tests
/ methods
Severe Acute Respiratory Syndrome
/ diagnosis
Spike Glycoprotein, Coronavirus
/ immunology
COVID-19
SARS
SARS-CoV-2
antibody
serology
Journal
Emerging microbes & infections
ISSN: 2222-1751
Titre abrégé: Emerg Microbes Infect
Pays: United States
ID NLM: 101594885
Informations de publication
Date de publication:
Dec 2020
Dec 2020
Historique:
pubmed:
13
6
2020
medline:
14
7
2020
entrez:
13
6
2020
Statut:
ppublish
Résumé
In response to the coronavirus disease 2019 (COVID-19) outbreak, caused by SARS-CoV-2, multiple diagnostic tests are required for acute disease diagnosis, contact tracing, monitoring asymptomatic infection rates and assessing herd immunity. While PCR remains the frontline test of choice in the acute diagnostic setting, serological tests are urgently needed. Unlike PCR tests which are highly specific, cross-reactivity is a major challenge for COVID-19 antibody tests considering there are six other coronaviruses known to infect humans. SARS-CoV is genetically related to SARS-CoV-2 sharing approximately 80% sequence identity and both belong to the species
Identifiants
pubmed: 32529906
doi: 10.1080/22221751.2020.1780951
pmc: PMC7473126
doi:
Substances chimiques
Antibodies, Viral
0
Coronavirus Nucleocapsid Proteins
0
Nucleocapsid Proteins
0
Phosphoproteins
0
Spike Glycoprotein, Coronavirus
0
nucleocapsid phosphoprotein, SARS-CoV-2
0
spike protein, SARS-CoV-2
0
Types de publication
Clinical Trial
Comparative Study
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1497-1505Références
Emerg Infect Dis. 1996 Jul-Sep;2(3):239-40
pubmed: 8903239
Lancet. 2020 Feb 15;395(10223):470-473
pubmed: 31986257
Science. 2003 Oct 10;302(5643):276-8
pubmed: 12958366
Nature. 2020 May;581(7807):221-224
pubmed: 32225175
FEMS Microbiol Rev. 2006 Sep;30(5):760-73
pubmed: 16911043
Antiviral Res. 2013 Oct;100(1):159-89
pubmed: 23906741
Lancet. 2020 Apr 4;395(10230):1101-1102
pubmed: 32247384
J Clin Microbiol. 2020 May 26;58(6):
pubmed: 32245835
Emerg Infect Dis. 2003 Jun;9(6):713-7
pubmed: 12781012
Nature. 2020 Mar;579(7798):270-273
pubmed: 32015507
Lancet Infect Dis. 2013 Oct;13(10):859-66
pubmed: 23933067
J Vis Exp. 2009 Oct 07;(32):
pubmed: 19812534
J Immunol Methods. 2000 Sep 21;243(1-2):243-55
pubmed: 10986418
Nat Med. 2020 Jul;26(7):1033-1036
pubmed: 32398876
Emerg Infect Dis. 2014 Apr;20(4):552-9
pubmed: 24655412
J Clin Microbiol. 2006 Jun;44(6):2063-71
pubmed: 16757599
Nature. 2018 Apr;556(7700):255-258
pubmed: 29618817
N Engl J Med. 2012 Nov 8;367(19):1814-20
pubmed: 23075143
Expert Rev Vaccines. 2010 Jun;9(6):567-78
pubmed: 20518713
Emerg Infect Dis. 2004 Dec;10(12):2244-8
pubmed: 15663874
Virology. 1992 Jan;186(1):318-23
pubmed: 1727608
Trends Immunol. 2020 May;41(5):355-359
pubmed: 32249063
JAMA. 2020 Apr 21;323(15):1488-1494
pubmed: 32125362
Nat Microbiol. 2020 Apr;5(4):536-544
pubmed: 32123347
Clin Diagn Lab Immunol. 2004 Mar;11(2):287-91
pubmed: 15013977
Emerg Infect Dis. 2020 Jul;26(7):1478-1488
pubmed: 32267220
J Clin Virol. 2003 Dec;28(3):245-7
pubmed: 14522062
Immunol Lett. 2009 Aug 15;125(2):79-85
pubmed: 19539648
Nature. 2020 May;581(7807):215-220
pubmed: 32225176
Science. 2005 Oct 28;310(5748):676-9
pubmed: 16195424
Syst Biol. 2010 May;59(3):307-21
pubmed: 20525638